The glycopolymers reversed Gal-3-induced changesin rat cardiac fibroblasts and VSMCs in vitro andaccumulated in rat lung and heart tissue, highlighting their potentialuse for pulmonary hypertension therapy. This evidence concerns the gene LGALS3 and pulmonary hypertension.